Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis

References

• Adhyatmika A, Putri KSS, Beljaars L, Melgert BN. (2015). The elusive antifibrotic macrophage. Front Med (Lausanne) 2:81.
   PubMed Web of Science ®Google Scholar
• Affò S, Rodrigo-Torres D, Blaya D, et al. (2015). Chemokine receptor Ccr6 deficiency alters hepatic inflammatory cell recruitment and promotes liver inflammation and fibrosis. Plos One 10:e0145147.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal RR. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–18.
   PubMed Web of Science ®Google Scholar
• Bagalkot V, Badgeley MA, Kampfrath T, et al. (2015). Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. J Control Release 217:243–55.
   PubMed Web of Science ®Google Scholar
• Bagalkot V, Deiuliis JA, Rajagopalan S, Maiseyeu A. (2016). “Eat me” imaging and therapy. Adv Drug Deliv Rev 99:2–11.
   PubMed Web of Science ®Google Scholar
• Bartneck M, Peters FM, Warzecha KT, et al. (2014). Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages. Nanomedicine 10:1209–20.
   PubMed Web of Science ®Google Scholar
• Bartneck M, Ritz T, Keul HA, et al. (2012). Peptide-functionalized gold nanorods increase liver injury in hepatitis. ACS Nano 6:8767–77.
   PubMed Web of Science ®Google Scholar
• Bartneck M, Warzecha KT, Tacke F. (2014). Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr 3:364–76.
   PubMedGoogle Scholar
• Bisht S, Khan MA, Bekhit M, et al. (2011). A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest 91:1383–95.
   PubMed Web of Science ®Google Scholar
• Byun JY, Youn YS, Lee YJ, et al. (2014). Interaction of apoptotic cells with macrophages upregulates COX-2/PGE2 and HGF expression via a positive feedback loop . Mediators Inflamm 2014:463524.
   PubMed Web of Science ®Google Scholar
• Chen N, Geng Q, Zheng J, et al. (2014). Suppression of the TGF-β/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis. Int J Mol Med 34:1110–16.
   PubMed Web of Science ®Google Scholar
• Duarte S, Baber J, Fujii T, Coito AJ. (2015). Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol 44–46:147–56.
   PubMed Web of Science ®Google Scholar
• Dvoriantchikova G, Agudelo C, Hernandez E, et al. (2009). Phosphatidylserine-containing liposomes promote maximal survival of retinal neurons after ischemic injury. J Cereb Blood Flow Metab 29:1755–9.
   PubMed Web of Science ®Google Scholar
• Fu Q, Hargrove D, Lu X. (2016). Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery. Nanomedicine 12:1951–9.
   PubMed Web of Science ®Google Scholar
• Fu Y, Zheng S, Lin J, et al. (2007). Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73:399–409.
   PubMed Web of Science ®Google Scholar
• Giannandrea M, Parks WC. (2014). Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech 7:193–203.
   PubMed Web of Science ®Google Scholar
• Harel-Adar T, Ben Mordechai T, Amsalem Y, et al. (2011). Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci USA 108:1827–32.
   PubMed Web of Science ®Google Scholar
• He C, Yin L, Tang C, Yin C. (2013). Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages. Biomaterials 34:2843–54.
   PubMed Web of Science ®Google Scholar
• Ju C, Tacke F. (2016). Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cell Mol Immunol 13:316–27.
   PubMed Web of Science ®Google Scholar
• Kansal S, Tandon R, Dwivedi P, et al. (2012). Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. J Antimicrob Chemother 67:2650–60.
   PubMed Web of Science ®Google Scholar
• Karin D, Koyama Y, Brenner D, Kisseleva T. (2016). The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis. Differentiation 92:84–92.
   PubMed Web of Science ®Google Scholar
• Li F, Li QH, Wang JY, et al. (2012). Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats. J Control Release 159:261–70.
   PubMed Web of Science ®Google Scholar
• Liu T, Li L, Fu C, et al. (2012). Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. Biomaterials 33:2399–407.
   PubMed Web of Science ®Google Scholar
• Liu T, Li L, Teng X, et al. (2011). Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 32:1657–68.
   PubMed Web of Science ®Google Scholar
• Magdaleno F, Arriazu E, Ruiz De Galarreta M, et al. (2016). Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis. J Hepatol 65:963–71.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Nakamura T. (1992). Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog 3:27–54.
   PubMedGoogle Scholar
• Mizuno S, Nakamura T. (2007). Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis. Regen Med 2:161–70.
   PubMed Web of Science ®Google Scholar
• Muntoni S, Rojkind M, Muntoni S. (2010). Colchicine reduces procollagen III and increases pseudocholinesterase in chronic liver disease. World J Gastroenterol 16:2889–94.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sakai K, Nakamura T, Matsumoto K. (2011). Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastoenterol Hepatol Suppl 1:188–202.
   Web of Science ®Google Scholar
• Ogaly HA, Eltablawy NA, EI-Behairy AM, et al. (2015). Hepatocyte growth factor mediates the antifibrogenic action of ocimum bacilicum essential oil against CCl4-induced liver fibrosis in rats. Molecules 20:13518–35.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Uchino R, Kawai A, et al. (2015). PEG modification on (111)In-labeled phosphatidyl serine liposomes for imaging of atherosclerotic plaques. Nucl Med Biol 42:299–304.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Umeda IO, Kosugi M, et al. (2014). Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging. J Nucl Med 55:115–20.
   PubMed Web of Science ®Google Scholar
• Onozuka I, Kakinuma S, Kamiya A, et al. (2011). Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice. Biochem Biophys Res Commun 406:134–40.
   PubMed Web of Science ®Google Scholar
• Park HJ, Baen JY, Lee YJ, et al. (2012). The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells. Mol Biol Cell 23:3254–65.
   PubMed Web of Science ®Google Scholar
• Pellicoro A, Aucott RL, Ramachandran P, et al. (2012). Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology 55:1965–75.
   PubMed Web of Science ®Google Scholar
• Popov Y, Sverdlov DY, Bhaskar KR, et al. (2010). Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. Am J Physiol Gastrointest Liver Physiol 298:G323–34.
   PubMed Web of Science ®Google Scholar
• Radbill BD, Gupta R, Ramirez MC, et al. (2011). Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression. Dig Dis Sci 56:406–16.
   PubMed Web of Science ®Google Scholar
• Ramachandran P, Pellicoro A, Vernon MA, et al. (2012). Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA 109:E3186–95.
   PubMed Web of Science ®Google Scholar
• Ravichandran KS. (2011). Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 35:445–55.
   PubMed Web of Science ®Google Scholar
• Reddy AT, Lakshmi SP, Zhang Y, Reddy RC. (2014). Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages. Faseb J 28:5299–310.
   PubMed Web of Science ®Google Scholar
• Salem NA, Ahmed HH, Aglan HA, Elshebiney SA. (2016). Nanofiber-expanded stem cells mitigate liver fibrosis: Experimental study. Tissue Cell 48:544–51.
   PubMed Web of Science ®Google Scholar
• Seo W, Eun HS, Kim SY, et al. (2016). Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis. Hepatology 64:616–31.
   PubMed Web of Science ®Google Scholar
• Shi D, Fu M, Fan P, et al. (2007). Artificial phosphatidylserine liposome mimics apoptotic cells in inhibiting maturation and immunostimulatory function of murine myeloid dendritic cells in response to 1-chloro-2,4-dinitrobenze in vitro. Arch Dermatol Res 299:327–36.
   PubMed Web of Science ®Google Scholar
• Shi H, Dong L, Jiang J, et al. (2013). Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology 303:107–14.
   PubMed Web of Science ®Google Scholar
• Shi H, Lv L, Cao H, et al. (2017). Bacterial translocation aggravates CCl4-induced liver cirrhosis by regulating CD4(+) T cells in rats. Sci Rep 7:40516.
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Lundqvist A, Strimfors M. (2012). Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in rats. Drug Dev Ind Pharm 39:1832–9.
   PubMed Web of Science ®Google Scholar
• Tacke F, Zimmermann HW. (2014). Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 60:1090–6.
   PubMed Web of Science ®Google Scholar
• Tu CT, Han B, Yao QY, et al. (2012a). Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression. Int Immunopharmacol 12:151–7.
   PubMed Web of Science ®Google Scholar
• Tu CT, Yao QY, Xu BL, et al. (2012b). Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression. Food Chem Toxicol 50:3343–51.
   PubMed Web of Science ®Google Scholar
• Wang J, Kang YX, Pan W, et al. (2016). Enhancement of anti-inflammatory activity of curcumin using phosphatidylserine-containing nanoparticles in cultured macrophages. Int J Mol Sci 17:969.
   Web of Science ®Google Scholar
• Wu N, Meng F, Invernizzi P, et al. (2016). The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice. Hepatology 64:865–79.
   PubMed Web of Science ®Google Scholar
• Wynn TA, Barron L. (2010). Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30:245–57.
   PubMed Web of Science ®Google Scholar
• Xi S, Shi M, Jiang X, et al. (2016). The effects of Tao-Hong-Si-Wu on hepatic necroinflammatory activity and fibrosis in a murine model of chronic liver disease. J Ethnopharmacol 180:28–36.
   PubMed Web of Science ®Google Scholar
• Yao Q, Lin Y, Li X, et al. (2013). Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis. Toxicol Lett 222:72–82.
   PubMed Web of Science ®Google Scholar
• Yoon YS, Kim SY, Kim MJ, et al. (2015). PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines. Mucosal Immunol 8:1031–46.
   PubMed Web of Science ®Google Scholar
• Zheng S, Chen A. (2006). Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 290:G883–93.
   PubMed Web of Science ®Google Scholar